Integra Lifesciences's total assets for Q1 2024 were $4.08B, an increase of 9.06% from the previous quarter. IART total liabilities were $2.48B for the fiscal quarter, a 14.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.